Emulsi Biotech

Emulsi Biotech is a pioneering biotechnology company specializing in the development of next-generation oral drug delivery systems. At the core of our operations is the NanoLIPID platform, an innovation built on advanced, multidisciplinary biotechnology and physical chemistry.

The platform operates on multiple levels: it solubilizes complex drug molecules, protects them within the harsh gastrointestinal environment, and enhances the overall bioavailability of biological therapeutics.

Day-to-day operations are focused on robust R&D and formulation engineering. By enabling safer, non-invasive, and more efficient oral delivery of complex biologics, Emulsi Biotech is poised to transform patient care, significantly lower healthcare costs, and dramatically expand global access to life-saving treatments.